BioInvent International AB
F:BIX0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioInvent International AB
F:BIX0
|
SE |
|
D
|
Duong Hieu Trading and Mining JSC
VN:DHM
|
VN |
|
Pieridae Energy Ltd
TSX:PEA
|
CA |
|
M
|
Mostostal Plock SA
WSE:MSP
|
PL |
|
BeMetals Corp
OTC:BMTLD
|
CA |
|
T
|
Thai Group Holdings PCL
SET:TGH
|
TH |
|
Vincerx Pharma Inc
OTC:VINC
|
US |
|
M
|
Maruhachi Warehouse Co Ltd
TSE:9313
|
JP |
|
G
|
G-Smatt Global Co Ltd
KOSDAQ:114570
|
KR |
|
Iris Acquisition Corp
OTC:IRAA
|
KY |
|
Clean Seas Seafood Ltd
ASX:CSS
|
AU |
|
Z
|
Zimtu Capital Corp
F:ZCT1
|
CA |
|
Wagners Holding Company Ltd
F:0W7
|
AU |
|
I
|
Incitec Pivot Ltd
XMUN:I5P
|
AU |
|
S
|
Silver X Mining Corp
DUS:AGX
|
CA |
|
Altitude Group PLC
F:D9E
|
UK |
|
Sonoran Desert Copper Corp
XTSX:BEM
|
CA |
|
Ebro Foods SA
OTC:EBRPF
|
ES |
|
Copper Search Ltd
ASX:CUS
|
AU |
|
Mapfre SA
F:CMA
|
ES |
|
D
|
Dynacolor Inc
TPEX:5489
|
TW |
Bankruptcy Probability
BioInvent International AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioInvent International AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
B
|
BioInvent International AB
STO:BINV
|
1.5B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
442.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
76.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioInvent International AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioInvent International AB has total debt of 1.2m SEK. This includes both short-term (0 SEK) and long-term (1.2m SEK) debt.
You can find a full breakdown on its Balance Sheet.
